Onconano Medicine

United States
Loretto, Tennessee, United States, 76092

Company profile

Onconano Medicine company profile

OncoNano Medicine is a biotech company that develops nanotechnology-enabled fluorescent probes to help cancer surgeons visualize tumors during surgery, allowing them to excise tumors more precisely. The fluorescent sensor targets the different pH signals, thus making them glow so they are easier to distinguish from normal tissue. OncoNano Medicine is a UTSW spinoff company based in Dallas, Texas.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2014-12-29

Headquarters

Postal code
76092
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
7
Total equity funding
$103.8M
Last funding
Series B / $18.4M / 2021-10-25
Last equity funding
Series B / $18.4M
Investors
4
Lead investors
3
Founders
1
Articles
41

Founders and investors

Founders

Ravi Srinivasan

Lead investors

Advantech CapitalCancer Prevention and Research Institute of TexasSalem Partners

Investors

Adam OkunAdvantech CapitalCancer Prevention and Research Institute of TexasSalem Partners